Skip to content
healthcare.dev

Dasatinib

NDC 72205-323, Dasatinib, tablet, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-323
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219579
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-323 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB100 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
72205-323-307220503233030 TABLET in 1 BOTTLE (72205-323-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bffb38c3-f556-492f-a9db-aa417ec0a856

Use it

Look up 72205-323 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-323 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-323. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.